Next Article in Journal
Longitudinal Plasma Lipidomics Reveals Distinct Signatures Following Surgery in Patients with Glioblastoma
Previous Article in Journal
Serum Uric Acid in the PAMELA Study: Main Findings and Association with the Atherogenic Index of Plasma
Previous Article in Special Issue
DNA Hypomethylation Is Associated with Increased Inflammation in Peripheral Blood Neutrophils of Children with Autism Spectrum Disorder: Understanding the Role of Ubiquitous Pollutant Di(2-ethylhexyl) Phthalate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Seledtsov et al. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123

by
Victor Ivanovich Seledtsov
1,2,*,
Adas Darinskas
1,
Alexei Von Delwig
1 and
Galina Victorovna Seledtsova
3
1
Innovita Research Company, 06116 Vilnius, Lithuania
2
Russian Scientific Center of Surgery Named after Academician B.V. Petrovsky, 119991 Moscow, Russia
3
Institute for Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia
*
Author to whom correspondence should be addressed.
Metabolites 2025, 15(10), 672; https://doi.org/10.3390/metabo15100672
Submission received: 9 October 2025 / Accepted: 10 October 2025 / Published: 15 October 2025
(This article belongs to the Special Issue Metabolism of Immune System in Inflammatory and Infectious Diseases)
Removal Affiliation
In the published publication [1], there was an error in the affiliation of Adas Darinskas. The affiliation National Cancer Institute, 08406 Vilnius, Lithuania, must be removed, and the correct affiliation is Innovita Research Company, 06116 Vilnius, Lithuania. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Seledtsov, V.I.; Darinskas, A.; Von Delwig, A.; Seledtsova, G.V. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Seledtsov, V.I.; Darinskas, A.; Von Delwig, A.; Seledtsova, G.V. Correction: Seledtsov et al. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123. Metabolites 2025, 15, 672. https://doi.org/10.3390/metabo15100672

AMA Style

Seledtsov VI, Darinskas A, Von Delwig A, Seledtsova GV. Correction: Seledtsov et al. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123. Metabolites. 2025; 15(10):672. https://doi.org/10.3390/metabo15100672

Chicago/Turabian Style

Seledtsov, Victor Ivanovich, Adas Darinskas, Alexei Von Delwig, and Galina Victorovna Seledtsova. 2025. "Correction: Seledtsov et al. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123" Metabolites 15, no. 10: 672. https://doi.org/10.3390/metabo15100672

APA Style

Seledtsov, V. I., Darinskas, A., Von Delwig, A., & Seledtsova, G. V. (2025). Correction: Seledtsov et al. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 2023, 13, 123. Metabolites, 15(10), 672. https://doi.org/10.3390/metabo15100672

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop